Review
Nature Reviews Neuroscience 9, 768-778 (October 2008) | doi:10.1038/nrn2494
Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses
Lars Bertram1 & Rudolph E. Tanzi1 About the authors
Abstract
The genetic underpinnings of Alzheimer's disease (AD) remain largely elusive despite early successes in identifying three genes that cause early-onset familial AD (those that encode amyloid precursor protein (APP) and the presenilins (PSEN1 and PSEN2)), and one genetic risk factor for late-onset AD (the gene that encodes apolipoprotein E (APOE)). A large number of studies that aimed to help uncover the remaining disease-related loci have been published in recent decades, collectively proposing or refuting the involvement of over 500 different gene candidates. Systematic meta-analyses of these studies currently highlight more than 20 loci that have modest but significant effects on AD risk. This Review discusses the putative pathogenetic roles and common biochemical pathways of some of the most genetically and biologically compelling of these potential AD risk factors.
- View At a Glance
Author affiliations
- Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Diseases (MIND), Department of Neurology, Massachusetts General Hospital, 114 16th Street, Charlestown, Massachusetts 02129, USA.
Correspondence to: Lars Bertram1 Email: bertram@helix.mgh.harvard.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Alzheimer?s disease beyond APOENature Genetics News and Views (01 Oct 2009)
Alzheimer disease ? when and why?Nature Genetics News and Views (01 Aug 1998)
See all 8 matches for News And ViewsRESEARCH
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's diseaseNature Genetics Letter (01 Oct 2009)
See all 11 matches for Research
